|
|
 |
|
Medical
Device Investor Day
October 19th, 2009
Being
Held Prior to In3 Summit
A
Full Day of Illuminating Presentations by the Most Influential
Large Companies in the Device Space
New for 2009 – Value-add Program!
- Investor Day will include presentations from large medical device companies AND from VCs that are interested in device investing.
- You asked for it! We listened. Additional time for networking, break-out sessions, and scheduled meetings. AND we’re separating break-outs from presentations, which means no schedule overlap so you maximize time in front of the investor community.
- More plenaries about the latest deal case studies, device investing, device M & A, health reform, clinicians, and more!
- VC hosted luncheon. Sign up for lunch (onsite) with the VC of your choice, at a personal table, among a small group.
Click
on the prices below to register |
Register for Investor Day ONLY: $795 |
Register for In3 Summit plus Investor Day |
| |
$300
Discount until 7/20/09 |
$200
Discount until 8/21/09 |
$100
Discount until 9/21/09 |
Full
Price after 9/21/09 |
| In3 Summit + Investor Day |
$1990 |
$2090 |
$2190 |
$2290 |
| In3 Summit + Investor Day addl. attendee |
$1890 |
$1990 |
$2090 |
$2190 |
For
more information, please contact Kristy Grimes at 480-985-9512,
888-202-5939 toll-free in the U.S., or e-mail kristy@medtechinsight.com
| Medical Device Investor Day is a unique event for medical technology executives interested in what the leaders of the med device industry are thinking, doing, and planning in terms of investment.
Top executives from each hand-selected company will speak candidly on what interests them most in medical device technologies, therapeutic areas, products, and geographic markets. They will also inform our audience about partnering opportunities, how companies can maximize their visibility in front of large company investors, and what role M&A plays at their companies.
Invited presenters for Medical Device Investor Day include Johnson & Johnson, Boston Scientific, Covidien, Abbott, Medtronic, Stryker, Zimmer, Edwards Lifesciences, Phillips Medical, BD, Hologic, GE, Baxter, St. Jude Medical, Biomet, and many others. Presentations will focus on these hot button topics:
- What
new technology/therapeutic areas do we find promising
and interesting in accessing via partnership?
- Product
or technologies of interest
- Geographic
markets
- Partnering
opportunities
-
How can companies maximize their visibility in front
of larger companies?
- What
role does M&A play at the company?
|
|
| back to top |
Presenting Companies
Medical
Device Investor Day
- Confirmed Presenters to Date -
Charles Warden, Managing Director - Versant Ventures
John F. Ryan, Partner, Medical Technology - ONSET Ventures
Mark Brooks, Managing Director - Scale Venture Partners
Scott Halsted, Managing Director - Saints Capital
John Lonergan, Managing General Partner - Medical Device Ventures LLC
Peter K. Shagory, Partner - Baird Venture Partners
Jan Garfinkle, Managing Director - Arboretum Ventures
Brian Chee, General Partner - Polaris Venture Partners
Walter Lin, MD, Investment Manager - Ascension Health Ventures
Chad Cornell, VP, Corporate Development - Medtronic
Ted Davis, Vice President, Business Development - Wright Medical Technology
Albert Lauritano, MSc, CLP, Director, Business Development - Becton Dickinson
Wendelin Maners, VP, Bus. Development/Strategy – Boston Scientific
Myles Greenberg, M.D., Partner - CHL Medical Partners
Jeani Delagardelle, Managing Director - New Leaf Venture Partners
Chanan Schneider, Managing General Partner - Agate Medical Investments LP
Richard Ferrari, Managing Director - De Novo Ventures
Evan Melrose, Managing Director - PTV Sciences
John Onopchenko, Managing Director - Synergy Life Science Partners
James A. Datin, Executive Vice President and Managing Director, Life Sciences Group - Safeguard Scientifics, Inc.
(Note: program subject to change)
|
|
| |
| Top
reasons to Attend Medical Device Investor Day:
-
It complements the early- to late-stage medical technology
investment and partnering focus of our “Investment In
Innovation (In3) East” conference, that immediately
follows this event.
-
Catch up on the state of, and outlook for, large medical technology
company investment and partnering – from the companies
themselves
-
Network with peers who face similar challenges in regulatory,
reimbursement and clinical issues for medical devices
-
Benchmark your dealmaking against the best and the brightest
-
Get key trend analysis on medical technology deal structures
-
Maximize your strategic alliance opportunities by meeting
business development leaders who’ll share practical
advice and strategies on how to structure successful deals
-
Walk away with practical, real-life lessons and advice from
some of the most experienced dealmakers in the worldwide medical
technology marketplace
Attendees
will include:
-
Presidents
-
CEOs
-
Chairmen
-
Venture Partners
-
Managing Directors
-
Vice Presidents/Directors of Business Development, Marketing,
New Technology, Acquisitions, R&D and Sales
-
Senior Investment Analysts/Managers/Directors
….
from these types of companies:
-
Established medical technology companies seeking technology
through licensing, partnering and acquisition to broaden or
deepen product lines or build sector strength
-
Early-stage medtech companies interested in what the leaders
of the industry have learned, and are looking for
-
Venture capitalists and investment bankers, and
- Medical
device, biotech, biopharmaceutical or other company executives
seeking investments or partnerships
The
med device industry is red hot, with the number of deals now
increasing each year. Medical Device Investor Day is an exclusive event for anyone interested in what the leaders
of the med device industry are thinking, doing, and planning
in terms of investment. We are expecting a record number of
participants – hurry and secure your spot today! |
| back to top |
Program Agenda
| October 19, 2009 |
| 8:00 - 8:45 AM |
Registration and Continental Breakfast
|
| 8:45 - 9:00 AM |
Large Companies and VCs Talk about What They Look for When Making Investment/Exit Strategy Choices
What are the strategic priorities?
How active is their deal making?
What value are they looking for?
Which therapeutic areas is the focus for outside technology sourcing?
What are some lessons learned from some of the deals done?
To what extent are you looking to buy products rather than companies or vice versa?
What’s the relationship or trade-off between deal-making and internal R&D investment?
How important a role will acquisitions play for going forward?
- David Cassak, Managing Director, Medical Devices, Elsevier Business Intelligence
|
| 9:00 - 9:15 AM |
Charles Warden, Managing Director - Versant Ventures
|
| 9:20 - 9:35 AM |
John Onopchenko, Managing Director - Synergy Life Science Partners
|
| 9:40 - 9:55 AM |
James A. Datin, Executive Vice President and Managing Director, Life Sciences Group - Safeguard Scientifics, Inc.
|
| 10:00 - 10:15 AM |
John F. Ryan, Partner, Medical Technology - ONSET Ventures
|
| 10:20 - 10:35 AM |
Mark Brooks, Managing Director - Scale Venture Partners
|
| 10:35 - 10:55 AM |
Networking Break
|
| 10:55 - 11:00 AM |
Moderator - Medmarc & The Hartford
|
| 11:00 - 11:15 AM |
Scott Halsted, Managing Director - Saints Capital
|
| 11:20 - 11:35 AM |
Kathy Tune, Principal - Thomas, McNerney & Partners
|
| 11:40 - 11:55 AM |
Peter K. Shagory, Partner - Baird Venture Partners
|
| 12:00 - 12:15 PM |
Chanan Schneider, Managing General Partner - Agate Medical Investments LP
|
| 12:20 - 12:35 PM |
Walter Lin, MD, Investment Manager - Ascension Health Ventures
|
| 12:40 - 1:55 PM |
Lunch
|
| 2:00 - 3:00 PM |
What are the Large Device Companies Shopping for?
What new technology/therapeutic areas do you find promising and interesting in accessing via investment?
What are the investing opportunities with large companies?
How can companies maximize their visibility in front of larger companies?
What role does M&A play at the company?
What kind of value are large companies looking for?
- Chad Cornell, VP, Corporate Development - Medtronic
- Ted Davis, Vice President, Business Development - Wright Medical Technology
- Albert Lauritano, MSc, CLP, Director, Business Development - Becton Dickinson
- Wendelin Maners, VP, Bus. Development/Strategy – Boston Scientific
|
| 3:05 - 3:10 PM |
Moderator - Intertek
|
| 3:10 - 3:25 PM |
Jeani Delagardelle, Managing Director - New Leaf Venture Partners
|
| 3:30 - 3:45 PM |
Myles Greenberg, M.D., Partner - CHL Medical Partners
|
| 3:50 - 4:05 PM |
Jan Garfinkle, Managing Director - Arboretum Ventures
|
| 4:10 - 4:25 PM |
Richard Ferrari, Managing Director - De Novo Ventures
|
| 4:30 - 4:45 PM |
Evan Melrose, Managing Director - PTV Sciences
|
| 4:50 - 5:05 PM |
Stephen Snowdy, PhD, Partner - MB Venture Partners
|
| 5:05 - 7:00 PM |
Pre-Conference Registration and Reception
|
| 6:00 - 7:00 PM |
Patent Strategies For Medical Device Companies - Case Studies From The Top Medical Device Cases of 2009
US Patent Office trends impacting medical device patents
Securing and enforcing medical method patents
Challenging medical device and method patents
Inducement of infringement for medical patents
Damages and injunctions for medical patents
- Joseph F. Jennings, Partner,Knobbe Martens
- Paul N. Conover, Partner, Knobbe Martens
- Matt Bellinger, Partner, Knobbe Martens
- Curtis R. Huffmire, Partner, Knobbe Martens - Moderator
|
|
*Cancellation
Policy: The last day to cancel your registration for
a refund, minus a $300 processing fee, is September 18, 2009. After that, you may send another delegate from your
company
|
| |
|
|
|
